SCHEMBL7311759

SCHEMBL7311759

CCOC(=O)C=CCNc1ccccc1C(N)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.48
MAPT P10636 4/20 0.48
MDM2 Q00987 1/20 0.48
KDM4E B2RXH2 6/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
PKM P14618 1/20 0.46
ALDH1A1 P00352 4/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
POLB P06746 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
HPGD P15428 1/20 0.42
THRB P10828 1/20 0.41
AGTR1 P30556 2/20 0.41
HSD17B10 Q99714 2/20 0.41
SIRT2 Q8IXJ6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7311755 1.00 LMNA (0.48) LMNAMAPTMDM2KDM4EMEN1
SCHEMBL7310907 0.83 ALDH1A1 (0.50) LMNAMAPTKDM4EMEN1KMT2A
SCHEMBL7310914 0.83 ALDH1A1 (0.50) LMNAMAPTKDM4EMEN1KMT2A
SCHEMBL9432247 0.82 MAPT (0.41) LMNAMAPTKDM4EMEN1KMT2A
SCHEMBL9432244 0.82 MAPT (0.41) LMNAMAPTKDM4EMEN1KMT2A
SCHEMBL3631342 0.77 MAPT (0.54) LMNAMAPTMDM2MEN1KMT2A
SCHEMBL9519629 0.77 MAPT (0.54) LMNAMAPTMDM2MEN1KMT2A
SCHEMBL4716443 0.76 MEN1 (0.52) LMNAKDM4EMEN1KMT2APKM
SCHEMBL9893975 0.75 MAPT (0.50) LMNAMAPTMDM2MEN1KMT2A
SCHEMBL9893976 0.75 MAPT (0.50) LMNAMAPTMDM2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5304560-A Treating CNS disorders; dopamine receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-19 US disclosed
EP-0481342-A1 Quinazoline derivatives and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP disclosed